FDA clears first migraine DTx from Click Therapeutics

FDA clears first migraine DTx from Click Therapeutics

Submitted by admin on April 16, 2025 - 11:11am
Source: 
Pharmaphorum
News Tags: 
Click Therapeutics
Medtech
digital therapeutics
DTx
CT-132
migraines
episodic migraines
FDA
Headline: 
FDA clears first migraine DTx from Click Therapeutics
snippet: 

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Do Not Allow Advertisers to Use My Personal information